Evidence map›Paper›PMID 32025964›Full record

ReviewCurrent treatment options in oncology2020

How Effective Is Palliative Care in Improving Patient Outcomes?

Sarah Milazzo, Eric Hansen, Desi Carozza, Amy A Case

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current treatment options in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Incidence of advanced chronic disease, need for palliative care and in-hospital mortalityRevista medica del Instituto Mexicano del Seguro Social · 2024
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarah MilazzoDepartment of Pediatrics State University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA.
Eric HansenDepartment of Supportive and Palliative Care, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Desi CarozzaDepartment of Supportive and Palliative Care, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Amy A CaseDepartment of Supportive and Palliative Care, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Amy.Case@RoswellPark.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

opinion statementAs palliative care (PC) continues its rapid growth, an emerging body of evidence is demonstrating that its approach of interdisciplinary supportive care benefits many patient populations, including in the oncology setting. As studies and data proliferate, however, questions persist about who, what, why, when, and how PC as well as the ideal time for a PC consult and length of involvement. When comparing outcomes from chemotherapy trials, it is important to consider the dosing regimens used in the various studies. In the same way, it is important to account for the "dose" of the PC interventions utilized across studies, and apples to apples comparisons are needed in order to draw accurate conclusions about PC's benefits. Studies which include a true interdisciplinary PC intervention consistently show improvements in patient quality of life, as well as cost savings, with further study needed for other outcomes. These benefits cannot be extrapolated to care which may be labeled "palliative care," but which does not meet the standard of true interdisciplinary PC. The ultimate question is: Does PC indeed improve outcomes?

Indexed as

CaregiversCosts and Cost AnalysisHumansNeoplasmsOutcome Assessment, Health CarePalliative CarePatient Reported Outcome MeasuresPatient SatisfactionPrognosisQuality of LifeCostOutcomesPalliative careQuality of lifeSatisfactionSupportiveSurvivalSymptoms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.